Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population‐based analysis
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16129 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Priscila Akemi Yamamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA. Hauptthemen laut MEDLINE: Carvedilol, Gastric Bypass, Models, Biological, Propanolamines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Aims
A population‐based pharmacokinetic (PK) modeling approach (PopPK) was used to investigate the impact of Roux‐en‐Y gastric bypass (RYGB) on the PK of ( R )‐ and ( S )‐carvedilol. We aimed to optimize carvedilol dosing for these patients utilizing a pharmacokinetic/pharmacodynamic (PK/PD) link model.
Methods
PopPK models were developed utilizing data from 52 subjects, including nonobese, obese, and post‐ RYGB patients who received rac ‐ carvedilol orally. Covariate analysis included anthropometric and laboratory data, history of RYGB surgery, CYP2D6 and CYP3A4 in vivo activity, and relative intestinal abundance of major drug‐ metabolizing enzymes and transporters. A direct effect inhibitory E max pharmacodynamic model was linked to the PK model of ( S )‐ carvedilol to simulate the changes in exercise‐ induced heart rate.
Results
A 2‐compartmental model with linear elimination and parallel first‐order absorptions best described ( S )‐carvedilol PK. RYGB led to a twofold reduction in relative oral bioavailability compared to nonoperated subjects, along with delayed absorption of both enantiomers. The intestinal ABCC2 mRNA expression increases the time to reach the maximum plasma concentration. The reduced exposure (AUC) of (S)‐carvedilol post‐RYGB corresponded to a 33% decrease in the predicted area under the effect curve (AUEC) for the 24‐hour β‐blocker response. Simulation results suggested that a 50‐mg daily dose in post‐RYGB patients achieved comparable AUC and AUEC to 25‐mg dose in nonoperated subjects.
Conclusion
Integrated PK/PD modeling indicated that standard dosage regimens for nonoperated subjects do not provide equivalent β‐blocking activity in RYGB patients. This study highlights the importance of personalized dosing strategies to attain desired therapeutic outcomes in this patient cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA.
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.
- Cancer Genetics Research Complex, College of Pharmacy, University of Florida, Gainesville, FL, USA.
- School of Medicine of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.
ORCID-Profile: Natalia Valadares de Moraes
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Yamamoto, P. A., Vozmediano, V., Cristofoletti, R., Jiang, J., Schmittgen, T. D., de Gaitani, C. M., Kemp, R., Sankarankutty, A. K., Dos Santos, J. S., Salgado Junior, W., & de Moraes, N. V. (2024). Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population‐based analysis. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16129
Vancouver
Yamamoto PA, Vozmediano V, Cristofoletti R, Jiang J, Schmittgen TD, de Gaitani CM, et al. Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population‐based analysis. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16129
BibTeX
@article{Yamamoto2024,
author = {Yamamoto, Priscila Akemi and Vozmediano, Valvanera and Cristofoletti, Rodrigo and Jiang, Jinmai and Schmittgen, Thomas D and de Gaitani, Cristiane Masetto and Kemp, Rafael and Sankarankutty, Ajith Kumar and Dos Santos, Jose Sebastião and Salgado Junior, Wilson and de Moraes, Natalia Valadares},
title = {Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population‐based analysis},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16129}
}
EUVIMED